License and Development Agreements (Details) (Collaborative agreement, Roche, USD $)
In Millions, unless otherwise specified |
1 Months Ended | 3 Months Ended | 12 Months Ended | 24 Months Ended | ||
---|---|---|---|---|---|---|
Jan. 31, 2009
|
Dec. 31, 2011
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
Collaborative agreement | Roche
|
||||||
License and Development Agreements | ||||||
Non-refundable upfront license payment received | $ 16 | |||||
Initial term for research | 2 years | |||||
Amount received related to research and development support | 21.2 | |||||
Accelerated recognition of remaining deferred revenue from upfront payment | 2.1 | |||||
License revenue recognized | 0 | 0 | 6.7 | |||
Cost sharing revenue recognized | $ 0 | $ 0 | $ 0 |